Washington, D.C. – Congresswoman Elise Stefanik voted today in favor of the Block, Report, and Suspend Shipments Act, bipartisan legislation that she cosponsors. Currently, under the Controlled Substances Act, drug manufacturers and distributors are required to notify the Drug Enforcement Administration when they discover any suspicious orders. The bill would require them to also exercise due diligence and halt any suspicious orders of opioids. Drug makers and distributors would have to keep records of their reports and include in their notices to the DEA the indicators that led to the suspicion.
“The opioid epidemic continues to wreak havoc on our North Country communities and communities across America,” said Congresswoman Stefanik. “This bipartisan legislation helps pharmacists and others be active partners in identifying exactly how opioids are distributed in our communities and stopping suspicious prescriptions from making their way in through a thorough reporting process. I applaud my House colleagues for coming together to pass this important bill, and I look forward to continuing my work in with local stakeholders and North Country communities to address the unfortunate opioid crisis and its impact.”